Please login to the form below

Not currently logged in
Email:
Password:

Unlicensed Avastin

This page shows the latest Unlicensed Avastin news and features for those working in and with pharma, biotech and healthcare.

NHS wins legal fight with pharma over off-label Avastin

NHS wins legal fight with pharma over off-label Avastin

A group of NHS organisations have claimed a legal victory against Bayer and Novartis, which had sought to stop them using Avastin as a cheap, unlicensed substitute for their ophthalmology drugs. ... The case could not only open the door for more

Latest news

  • Bayer to challenge Avastin legal ruling Bayer to challenge Avastin legal ruling

    Bayer to challenge Avastin legal ruling. Both sides claim to be acting in patients' best interest. ... of rows over unlicensed use of Avastin in AMD.

  • Novartis 'in negotiations' over price of Lucentis in UK Novartis 'in negotiations' over price of Lucentis in UK

    However, at UK NHS prices Lucentis costs £741 per vial, compared to just £40 for Avastin. ... Novartis meanwhile has said there are serious safety concerns associated with the use of unlicensed Avastin in AMD, and has initiated legal proceedings

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics